progression-free survival
-
August 15, 2020
In a First, Proton Therapy Bests Radiotherapy in an RCT Bookmark
George Lundberg, MDArticle from Medscape curated by Editor in Chief George Lundberg, MD, who notes:
In a clinical trial that compared proton beam therapy with standard radiotherapy for esophageal cancer, the two treatments were found to be virtually identical in terms of progression-free survival, overall survival, and quality of life.
Go to full news article published by Medscape.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
-
December 13, 2019
PARP Inhibitors Center Stage for Ovarian Cancer Bookmark
George Lundberg, MDArticle from Medscape curated by Editor in Chief George Lundberg, MD, who notes:
Drugs known as PARP inhibitors can improve progression-free survival (PFS) in many patients with advanced ovarian cancers.
Go to full article published by Medscape.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
-
December 2, 2019
Deciding on the Ideal First-Line Treatment for Rare and Advanced Kidney Cancers Bookmark
George Lundberg, MDArticle from Targeted Oncology curated by Editor in Chief George Lundberg, MD, who notes:
In recent clinical trials, the drug cabozantinib is being found to greatly increase progression-free survival.
Go to full article published by Targeted Oncology.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.